Bach Pharma Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $500K

Bach Pharma General Information

Description

Developer of pharmaceutical drug candidates designed to support the treatment of neurodegenerative and life-threatening diseases. The company conducts research on phthalazinedione-based compounds with antioxidant, anti-inflammatory, and cell-protective properties, focusing on oxidative stress regulation, cellular protection, and inflammatory response management, enabling pharmaceutical researchers and healthcare organizations to investigate potential treatments for neurological disorders and other conditions associated with cellular damage.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Corporate Office
  • 60 Dale Road
  • Meredith, NH 03253
  • United States
+1 (508)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 60 Dale Road
  • Meredith, NH 03253
  • United States
+1 (508)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bach Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 14-Aug-2019 $500K Completed Generating Revenue
To view Bach Pharma’s complete valuation and funding history, request access »

Bach Pharma Patents

Bach Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210161890-A1 Compositions and methods for treating brain dysfunction Inactive 31-Dec-2015
EP-3397257-A1 Compositions and nethods for treating brain dysfunction Inactive 31-Dec-2015
EP-3397257-A4 Compositions and nethods for treating brain dysfunction Inactive 31-Dec-2015
WO-2017117586-A1 Compositions and nethods for treating brain dysfunction Inactive 31-Dec-2015
WO-2014145472-A3 A method for treating neurodegeneration using a p38mapk inhibitor Inactive 15-Mar-2013 A61K31/4439
To view Bach Pharma’s complete patent history, request access »

Bach Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bach Pharma FAQs

  • When was Bach Pharma founded?

    Bach Pharma was founded in 2001.

  • Where is Bach Pharma headquartered?

    Bach Pharma is headquartered in Meredith, NH.

  • What is the size of Bach Pharma?

    Bach Pharma has 6 total employees.

  • What industry is Bach Pharma in?

    Bach Pharma’s primary industry is Drug Discovery.

  • Is Bach Pharma a private or public company?

    Bach Pharma is a Private company.

  • What is Bach Pharma’s current revenue?

    The current revenue for Bach Pharma is .

  • How much funding has Bach Pharma raised over time?

    Bach Pharma has raised $500K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process